Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Anemia, Sickle Cell | 39 | 2019 | 1065 | 1.960 |
Why?
|
Hydroxyurea | 10 | 2010 | 284 | 0.700 |
Why?
|
Antisickling Agents | 5 | 2008 | 72 | 0.620 |
Why?
|
Reticulocytes | 9 | 1999 | 287 | 0.570 |
Why?
|
Fetal Hemoglobin | 9 | 2019 | 346 | 0.450 |
Why?
|
Quantitative Trait Loci | 3 | 2007 | 2131 | 0.440 |
Why?
|
Hemoglobins | 11 | 2010 | 1531 | 0.390 |
Why?
|
Connexins | 3 | 2008 | 355 | 0.380 |
Why?
|
Erythropoiesis | 4 | 2006 | 691 | 0.330 |
Why?
|
Blood Cell Count | 3 | 2007 | 406 | 0.330 |
Why?
|
Erythrocyte Membrane | 6 | 2003 | 438 | 0.320 |
Why?
|
Clotrimazole | 4 | 1996 | 76 | 0.310 |
Why?
|
Deafness | 2 | 2003 | 460 | 0.310 |
Why?
|
Papio | 2 | 2007 | 671 | 0.300 |
Why?
|
Leukocyte Count | 5 | 2019 | 1609 | 0.280 |
Why?
|
Erythrocytes | 10 | 1996 | 2418 | 0.270 |
Why?
|
Potassium Channel Blockers | 3 | 1996 | 162 | 0.270 |
Why?
|
Chromosomes, Human, Pair 16 | 3 | 2011 | 341 | 0.230 |
Why?
|
Spectrin | 5 | 1995 | 176 | 0.230 |
Why?
|
Quantitative Trait, Heritable | 3 | 2019 | 540 | 0.230 |
Why?
|
Platelet Count | 2 | 2005 | 787 | 0.230 |
Why?
|
Blood Transfusion | 3 | 2005 | 1308 | 0.210 |
Why?
|
Blood Cells | 1 | 2005 | 309 | 0.210 |
Why?
|
Chromosomes | 1 | 2006 | 578 | 0.210 |
Why?
|
Anion Exchange Protein 1, Erythrocyte | 4 | 2003 | 150 | 0.200 |
Why?
|
Ankyrins | 5 | 1995 | 123 | 0.190 |
Why?
|
Chromosome Mapping | 2 | 2007 | 4618 | 0.190 |
Why?
|
Sequence Deletion | 2 | 2011 | 1494 | 0.180 |
Why?
|
Hemoglobin, Sickle | 3 | 2003 | 113 | 0.170 |
Why?
|
Hemoglobin SC Disease | 3 | 1994 | 23 | 0.160 |
Why?
|
Cytoskeletal Proteins | 3 | 1995 | 1327 | 0.150 |
Why?
|
Neuropeptides | 3 | 1995 | 951 | 0.150 |
Why?
|
Anemia, Iron-Deficiency | 2 | 1999 | 372 | 0.150 |
Why?
|
Erythrocytes, Abnormal | 4 | 1997 | 121 | 0.140 |
Why?
|
Blood Platelets | 2 | 2005 | 2479 | 0.120 |
Why?
|
Base Sequence | 3 | 2009 | 12418 | 0.120 |
Why?
|
Chromosome Deletion | 2 | 2011 | 1384 | 0.120 |
Why?
|
Crosses, Genetic | 2 | 2006 | 752 | 0.120 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2006 | 277 | 0.110 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 6071 | 0.110 |
Why?
|
Membrane Proteins | 5 | 1995 | 7876 | 0.110 |
Why?
|
Stroke | 2 | 2006 | 9755 | 0.110 |
Why?
|
Chromosome Aberrations | 3 | 2008 | 1777 | 0.110 |
Why?
|
Membrane Transport Proteins | 2 | 2009 | 1037 | 0.110 |
Why?
|
Genetic Variation | 3 | 2008 | 6611 | 0.090 |
Why?
|
Globins | 1 | 1992 | 405 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2007 | 618 | 0.090 |
Why?
|
Erythrocyte Count | 2 | 2006 | 157 | 0.090 |
Why?
|
Conserved Sequence | 1 | 1993 | 1162 | 0.090 |
Why?
|
Hemoglobins, Abnormal | 2 | 1988 | 119 | 0.090 |
Why?
|
Mutation | 6 | 2011 | 30211 | 0.090 |
Why?
|
Cytoprotection | 1 | 2010 | 199 | 0.080 |
Why?
|
Lung Diseases | 1 | 2000 | 1944 | 0.080 |
Why?
|
Hemolysis | 5 | 2010 | 417 | 0.080 |
Why?
|
Reperfusion Injury | 2 | 2010 | 1039 | 0.080 |
Why?
|
Gene Dosage | 2 | 2011 | 1211 | 0.080 |
Why?
|
Fever | 1 | 1997 | 1613 | 0.080 |
Why?
|
Pain | 3 | 1994 | 5100 | 0.080 |
Why?
|
Heinz Bodies | 1 | 1988 | 5 | 0.080 |
Why?
|
Hematocrit | 2 | 2006 | 623 | 0.080 |
Why?
|
Cell Adhesion | 3 | 1995 | 3096 | 0.080 |
Why?
|
Physical Exertion | 2 | 1982 | 668 | 0.080 |
Why?
|
DNA Mutational Analysis | 4 | 2009 | 4114 | 0.080 |
Why?
|
Anemia, Hemolytic | 2 | 1981 | 164 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 1995 | 1613 | 0.080 |
Why?
|
Hemoglobin A | 3 | 2003 | 84 | 0.080 |
Why?
|
Bone Marrow Transplantation | 1 | 1996 | 2710 | 0.080 |
Why?
|
Hypertension, Pulmonary | 2 | 2010 | 1605 | 0.070 |
Why?
|
Thinness | 1 | 2011 | 482 | 0.070 |
Why?
|
Family | 1 | 2019 | 3210 | 0.070 |
Why?
|
Phosphodiesterase 4 Inhibitors | 1 | 2008 | 37 | 0.070 |
Why?
|
Synteny | 1 | 2007 | 77 | 0.070 |
Why?
|
Mice, Inbred Strains | 2 | 2010 | 1765 | 0.070 |
Why?
|
Life Expectancy | 1 | 1994 | 1248 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2008 | 213 | 0.070 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 1988 | 184 | 0.070 |
Why?
|
Mice, Inbred NZB | 1 | 2006 | 57 | 0.070 |
Why?
|
Humans | 66 | 2019 | 767991 | 0.070 |
Why?
|
Hematologic Tests | 2 | 2005 | 239 | 0.060 |
Why?
|
Ambulatory Care | 1 | 1997 | 2781 | 0.060 |
Why?
|
Regression Analysis | 4 | 2005 | 6339 | 0.060 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2009 | 1534 | 0.060 |
Why?
|
Child | 20 | 2011 | 80906 | 0.060 |
Why?
|
Calcium | 3 | 1995 | 5794 | 0.060 |
Why?
|
Administration, Oral | 5 | 1997 | 4030 | 0.060 |
Why?
|
Alleles | 3 | 2009 | 6894 | 0.060 |
Why?
|
Streptococcus mutans | 1 | 2005 | 99 | 0.060 |
Why?
|
Lod Score | 1 | 2005 | 600 | 0.060 |
Why?
|
Erythrocyte Indices | 1 | 2005 | 143 | 0.060 |
Why?
|
Nitric Oxide | 2 | 2010 | 2146 | 0.060 |
Why?
|
Blood Volume | 1 | 2005 | 545 | 0.060 |
Why?
|
Oxygen | 3 | 2005 | 4269 | 0.060 |
Why?
|
Rheology | 2 | 1982 | 348 | 0.060 |
Why?
|
Water-Electrolyte Balance | 3 | 1997 | 326 | 0.060 |
Why?
|
Erythrocyte Transfusion | 1 | 1988 | 575 | 0.050 |
Why?
|
Cerebral Arteries | 1 | 2005 | 490 | 0.050 |
Why?
|
Female | 29 | 2019 | 397113 | 0.050 |
Why?
|
Thalassemia | 4 | 1991 | 267 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2011 | 3798 | 0.050 |
Why?
|
Inheritance Patterns | 1 | 2005 | 344 | 0.050 |
Why?
|
Phenotype | 3 | 2011 | 16723 | 0.050 |
Why?
|
Growth | 1 | 1984 | 366 | 0.050 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2008 | 783 | 0.050 |
Why?
|
Blood Flow Velocity | 1 | 2005 | 1375 | 0.050 |
Why?
|
Liver Diseases | 1 | 2010 | 1305 | 0.050 |
Why?
|
Hearing Loss | 1 | 2009 | 785 | 0.050 |
Why?
|
Animals | 16 | 2010 | 169222 | 0.050 |
Why?
|
Kinetics | 6 | 2003 | 6328 | 0.050 |
Why?
|
Potassium | 5 | 1997 | 1314 | 0.050 |
Why?
|
Reference Values | 4 | 1997 | 4938 | 0.050 |
Why?
|
Species Specificity | 1 | 2005 | 2415 | 0.050 |
Why?
|
Male | 25 | 2019 | 364641 | 0.050 |
Why?
|
Dental Caries | 1 | 2005 | 429 | 0.050 |
Why?
|
Genotype | 4 | 2011 | 13042 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2011 | 2650 | 0.050 |
Why?
|
Inflammation | 1 | 2000 | 10871 | 0.040 |
Why?
|
Azacitidine | 3 | 1995 | 336 | 0.040 |
Why?
|
Embolism, Fat | 1 | 2000 | 46 | 0.040 |
Why?
|
Swimming | 1 | 1981 | 209 | 0.040 |
Why?
|
Saliva | 1 | 2005 | 853 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2005 | 640 | 0.040 |
Why?
|
Vitamin K Deficiency Bleeding | 1 | 1979 | 9 | 0.040 |
Why?
|
Models, Biological | 2 | 2010 | 9493 | 0.040 |
Why?
|
Obesity | 2 | 2011 | 13091 | 0.040 |
Why?
|
Mice, Transgenic | 4 | 2010 | 9556 | 0.040 |
Why?
|
Autistic Disorder | 1 | 2008 | 1240 | 0.040 |
Why?
|
Reticulocyte Count | 1 | 1997 | 36 | 0.040 |
Why?
|
Child, Preschool | 9 | 2011 | 42665 | 0.040 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 1997 | 66 | 0.040 |
Why?
|
Blood Chemical Analysis | 1 | 1999 | 435 | 0.040 |
Why?
|
Mice | 7 | 2010 | 82024 | 0.030 |
Why?
|
Adult | 22 | 2019 | 223583 | 0.030 |
Why?
|
Developmental Disabilities | 3 | 2011 | 1518 | 0.030 |
Why?
|
Itraconazole | 1 | 1995 | 43 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2008 | 4785 | 0.030 |
Why?
|
Aging | 2 | 2011 | 8744 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1995 | 1731 | 0.030 |
Why?
|
Rosette Formation | 1 | 1995 | 152 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 1997 | 1377 | 0.030 |
Why?
|
Disease Management | 1 | 2006 | 2533 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2002 | 1542 | 0.030 |
Why?
|
Adolescent | 11 | 2011 | 89155 | 0.030 |
Why?
|
Leukemia, T-Cell | 1 | 1995 | 102 | 0.030 |
Why?
|
L-Lactate Dehydrogenase | 2 | 2010 | 412 | 0.030 |
Why?
|
Cerebral Infarction | 1 | 1999 | 969 | 0.030 |
Why?
|
Magnesium | 1 | 1997 | 815 | 0.030 |
Why?
|
Protein Binding | 3 | 1995 | 9343 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2005 | 12075 | 0.030 |
Why?
|
Hematology | 1 | 1997 | 243 | 0.030 |
Why?
|
Nonverbal Communication | 1 | 1994 | 62 | 0.030 |
Why?
|
Chlorides | 2 | 2009 | 666 | 0.030 |
Why?
|
Body Mass Index | 1 | 2011 | 13053 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 1995 | 866 | 0.030 |
Why?
|
Blood Proteins | 2 | 1989 | 1191 | 0.030 |
Why?
|
Chest Pain | 1 | 2000 | 1101 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 1995 | 300 | 0.030 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 1995 | 249 | 0.030 |
Why?
|
DNA | 2 | 2003 | 7213 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 2 | 1995 | 2473 | 0.030 |
Why?
|
Erythropoietin | 1 | 1997 | 718 | 0.030 |
Why?
|
Infant | 5 | 2011 | 36534 | 0.030 |
Why?
|
Hydrolysis | 1 | 1993 | 646 | 0.030 |
Why?
|
China | 2 | 2009 | 2395 | 0.030 |
Why?
|
E-Selectin | 1 | 1995 | 577 | 0.030 |
Why?
|
Methylprednisolone | 1 | 1994 | 386 | 0.030 |
Why?
|
2,3-Diphosphoglycerate | 2 | 2003 | 13 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 1995 | 693 | 0.020 |
Why?
|
Body Height | 2 | 2011 | 1565 | 0.020 |
Why?
|
Probability | 2 | 1994 | 2479 | 0.020 |
Why?
|
beta-Thalassemia | 1 | 1994 | 234 | 0.020 |
Why?
|
Gene Frequency | 2 | 2009 | 3623 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2010 | 22381 | 0.020 |
Why?
|
Growth and Development | 1 | 2011 | 46 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2000 | 6515 | 0.020 |
Why?
|
Pyruvate Kinase | 2 | 1986 | 191 | 0.020 |
Why?
|
Fibronectins | 2 | 1985 | 722 | 0.020 |
Why?
|
Amino Acid Sequence | 3 | 2003 | 13420 | 0.020 |
Why?
|
Ion Channels | 2 | 1986 | 1044 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2008 | 7445 | 0.020 |
Why?
|
Clinical Clerkship | 2 | 1994 | 569 | 0.020 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2010 | 67 | 0.020 |
Why?
|
Cell Division | 1 | 1978 | 4473 | 0.020 |
Why?
|
Peroxiredoxins | 1 | 2010 | 51 | 0.020 |
Why?
|
Endothelium, Vascular | 2 | 2010 | 4427 | 0.020 |
Why?
|
Antifungal Agents | 1 | 1995 | 761 | 0.020 |
Why?
|
Priapism | 1 | 2010 | 28 | 0.020 |
Why?
|
Gene Duplication | 1 | 2011 | 315 | 0.020 |
Why?
|
Karyotyping | 1 | 1992 | 1176 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 474 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2011 | 18062 | 0.020 |
Why?
|
Leg Ulcer | 1 | 2010 | 71 | 0.020 |
Why?
|
Binding Sites | 2 | 2000 | 6022 | 0.020 |
Why?
|
Students, Medical | 2 | 1994 | 1963 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 1995 | 3055 | 0.020 |
Why?
|
Acute Disease | 1 | 2000 | 7241 | 0.020 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2010 | 96 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 1992 | 606 | 0.020 |
Why?
|
Chromosome Disorders | 1 | 1992 | 498 | 0.020 |
Why?
|
DNA Primers | 1 | 1993 | 2827 | 0.020 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2010 | 514 | 0.020 |
Why?
|
Imidazoles | 1 | 1995 | 1168 | 0.020 |
Why?
|
Phenylhydrazines | 1 | 1988 | 28 | 0.020 |
Why?
|
Sodium | 3 | 1997 | 1597 | 0.020 |
Why?
|
Iron | 1 | 1997 | 1813 | 0.020 |
Why?
|
Vestibular Aqueduct | 1 | 2009 | 73 | 0.020 |
Why?
|
Rolipram | 1 | 2008 | 24 | 0.020 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2010 | 394 | 0.020 |
Why?
|
Ion Transport | 1 | 2009 | 323 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 1992 | 602 | 0.020 |
Why?
|
Heme Oxygenase-1 | 1 | 2010 | 364 | 0.020 |
Why?
|
Energy Metabolism | 2 | 2011 | 2908 | 0.020 |
Why?
|
North America | 1 | 2011 | 1289 | 0.020 |
Why?
|
Clinical Trials as Topic | 3 | 2010 | 8052 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2010 | 962 | 0.020 |
Why?
|
Erythroblasts | 1 | 1987 | 142 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2010 | 706 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1995 | 6119 | 0.020 |
Why?
|
Transfection | 1 | 1995 | 5757 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2003 | 5151 | 0.020 |
Why?
|
Pulmonary Embolism | 1 | 2000 | 2599 | 0.020 |
Why?
|
Anemia, Hemolytic, Congenital | 1 | 1986 | 71 | 0.020 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2008 | 361 | 0.020 |
Why?
|
Geography | 1 | 2008 | 652 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2010 | 898 | 0.020 |
Why?
|
Infant, Newborn | 4 | 2011 | 26420 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2011 | 12797 | 0.020 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2010 | 362 | 0.020 |
Why?
|
Haplotypes | 1 | 1992 | 2722 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2000 | 17617 | 0.020 |
Why?
|
Granulomatous Disease, Chronic | 1 | 1986 | 175 | 0.020 |
Why?
|
Head | 1 | 2011 | 926 | 0.020 |
Why?
|
DMF Index | 1 | 2005 | 87 | 0.020 |
Why?
|
Superoxides | 1 | 1986 | 389 | 0.020 |
Why?
|
Microcirculation | 1 | 2010 | 1281 | 0.020 |
Why?
|
Educational Measurement | 1 | 1992 | 1260 | 0.020 |
Why?
|
Xenopus laevis | 1 | 2009 | 967 | 0.020 |
Why?
|
Biological Transport | 3 | 1997 | 2085 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 1993 | 3740 | 0.020 |
Why?
|
Urinary Bladder | 1 | 1991 | 1157 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2010 | 1736 | 0.010 |
Why?
|
RNA | 1 | 1995 | 2718 | 0.010 |
Why?
|
Heterozygote | 1 | 2011 | 2798 | 0.010 |
Why?
|
Europe | 1 | 2011 | 3437 | 0.010 |
Why?
|
Dietary Supplements | 1 | 1997 | 3445 | 0.010 |
Why?
|
Oocytes | 1 | 2009 | 1172 | 0.010 |
Why?
|
Patient Selection | 1 | 1996 | 4258 | 0.010 |
Why?
|
Faculty, Medical | 1 | 1992 | 1225 | 0.010 |
Why?
|
Thromboembolism | 1 | 2010 | 1003 | 0.010 |
Why?
|
Cause of Death | 1 | 1994 | 3720 | 0.010 |
Why?
|
Hepatocytes | 1 | 2010 | 1247 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4576 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2003 | 323 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2009 | 1972 | 0.010 |
Why?
|
Sepsis | 1 | 1997 | 2608 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5024 | 0.010 |
Why?
|
Cytarabine | 1 | 1985 | 695 | 0.010 |
Why?
|
Cohort Studies | 2 | 2019 | 41749 | 0.010 |
Why?
|
Lipid Bilayers | 1 | 1985 | 379 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1999 | 15442 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 1989 | 2227 | 0.010 |
Why?
|
Sexual Maturation | 1 | 1984 | 258 | 0.010 |
Why?
|
Membrane Fluidity | 1 | 1982 | 67 | 0.010 |
Why?
|
Granulocytes | 1 | 1984 | 551 | 0.010 |
Why?
|
Disease Models, Animal | 3 | 2010 | 18344 | 0.010 |
Why?
|
Erythrocyte Aging | 1 | 1981 | 52 | 0.010 |
Why?
|
NF-kappa B | 1 | 2010 | 2493 | 0.010 |
Why?
|
Penicillins | 1 | 2005 | 404 | 0.010 |
Why?
|
Methylation | 1 | 1984 | 1078 | 0.010 |
Why?
|
Desiccation | 1 | 1981 | 78 | 0.010 |
Why?
|
Drug Monitoring | 2 | 1999 | 964 | 0.010 |
Why?
|
Survival Analysis | 1 | 1994 | 10098 | 0.010 |
Why?
|
Menarche | 1 | 1984 | 538 | 0.010 |
Why?
|
Hemoglobinopathies | 2 | 1980 | 101 | 0.010 |
Why?
|
Actins | 1 | 1988 | 2064 | 0.010 |
Why?
|
Pregnancy | 3 | 2011 | 30260 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2011 | 22287 | 0.010 |
Why?
|
Glycosides | 1 | 1980 | 99 | 0.010 |
Why?
|
Methemoglobinemia | 1 | 1980 | 45 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 2007 | 1424 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1992 | 10757 | 0.010 |
Why?
|
Nitrites | 1 | 1980 | 156 | 0.010 |
Why?
|
Prothrombin Time | 1 | 1979 | 117 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 1988 | 2819 | 0.010 |
Why?
|
Brain | 1 | 2005 | 27366 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4146 | 0.010 |
Why?
|
Allosteric Regulation | 1 | 2000 | 426 | 0.010 |
Why?
|
Phosphoglycerate Kinase | 1 | 1978 | 66 | 0.010 |
Why?
|
Dimerization | 1 | 2000 | 887 | 0.010 |
Why?
|
Valine | 1 | 2000 | 410 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 36742 | 0.010 |
Why?
|
Anemia, Neonatal | 1 | 1978 | 19 | 0.010 |
Why?
|
Avitaminosis | 1 | 1978 | 35 | 0.010 |
Why?
|
Blood Coagulation Tests | 1 | 1979 | 269 | 0.010 |
Why?
|
Risk Factors | 3 | 1999 | 74936 | 0.010 |
Why?
|
Clinical Competence | 1 | 1994 | 4857 | 0.010 |
Why?
|
Hyperbilirubinemia | 1 | 1978 | 74 | 0.010 |
Why?
|
Erythrocyte Deformability | 1 | 1997 | 55 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1995 | 9252 | 0.010 |
Why?
|
Spherocytosis, Hereditary | 1 | 1978 | 83 | 0.010 |
Why?
|
Erythroblastosis, Fetal | 1 | 1978 | 62 | 0.010 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 1978 | 94 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2011 | 7612 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2010 | 19017 | 0.010 |
Why?
|
Homozygote | 1 | 1982 | 1778 | 0.010 |
Why?
|
Blood Group Incompatibility | 1 | 1978 | 134 | 0.010 |
Why?
|
Survival Rate | 1 | 1991 | 12828 | 0.010 |
Why?
|
Immune System Diseases | 1 | 1979 | 253 | 0.010 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1978 | 209 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2000 | 1683 | 0.010 |
Why?
|
Haptoglobins | 1 | 1978 | 165 | 0.010 |
Why?
|
Glycine | 1 | 2000 | 672 | 0.010 |
Why?
|
Hemostasis | 1 | 1979 | 468 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 1981 | 1676 | 0.010 |
Why?
|
Acetonitriles | 1 | 1995 | 55 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9536 | 0.010 |
Why?
|
Aged | 3 | 2011 | 171446 | 0.010 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1997 | 480 | 0.010 |
Why?
|
Age Factors | 1 | 1991 | 18407 | 0.010 |
Why?
|
Bone Marrow | 1 | 1984 | 2935 | 0.010 |
Why?
|
Hypotension | 1 | 1980 | 888 | 0.010 |
Why?
|
Neutrophils | 1 | 1986 | 3786 | 0.010 |
Why?
|
Middle Aged | 3 | 2011 | 223422 | 0.010 |
Why?
|
Body Weight | 1 | 1984 | 4628 | 0.010 |
Why?
|
Splenectomy | 2 | 1985 | 392 | 0.010 |
Why?
|
Young Adult | 2 | 2011 | 60048 | 0.010 |
Why?
|
Incidence | 1 | 1991 | 21532 | 0.010 |
Why?
|
Respiration | 1 | 1979 | 1661 | 0.010 |
Why?
|
Videotape Recording | 1 | 1994 | 335 | 0.010 |
Why?
|
Protein Conformation | 1 | 2000 | 3956 | 0.010 |
Why?
|
United States | 2 | 2009 | 73027 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2011 | 12795 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 1984 | 3409 | 0.010 |
Why?
|
Bufo marinus | 1 | 1991 | 32 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 1995 | 644 | 0.010 |
Why?
|
Isoelectric Focusing | 1 | 1991 | 149 | 0.010 |
Why?
|
Mental Disorders | 1 | 2011 | 6875 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 1979 | 1179 | 0.010 |
Why?
|
Prevalence | 1 | 2008 | 15867 | 0.010 |
Why?
|
Peptide Mapping | 1 | 1991 | 260 | 0.010 |
Why?
|
Group Processes | 1 | 1992 | 226 | 0.010 |
Why?
|
Drug Interactions | 1 | 1995 | 1419 | 0.010 |
Why?
|
Adenosine Triphosphatases | 1 | 1995 | 842 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 1995 | 682 | 0.010 |
Why?
|
Retrospective Studies | 1 | 1999 | 81746 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1992 | 1625 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1978 | 1397 | 0.010 |
Why?
|
Rabbits | 2 | 1985 | 4771 | 0.000 |
Why?
|
Immunoblotting | 1 | 1991 | 1647 | 0.000 |
Why?
|
Phosphates | 1 | 1991 | 765 | 0.000 |
Why?
|
4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 1 | 1986 | 33 | 0.000 |
Why?
|
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1986 | 59 | 0.000 |
Why?
|
Triglycerides | 1 | 1995 | 2463 | 0.000 |
Why?
|
Cytochrome b Group | 1 | 1986 | 59 | 0.000 |
Why?
|
Flavoproteins | 1 | 1986 | 40 | 0.000 |
Why?
|
Adenosine Triphosphate | 2 | 1986 | 2004 | 0.000 |
Why?
|
Ouabain | 1 | 1986 | 246 | 0.000 |
Why?
|
Epithelium | 1 | 1991 | 1607 | 0.000 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1986 | 96 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2005 | 7470 | 0.000 |
Why?
|
Cell Compartmentation | 1 | 1986 | 383 | 0.000 |
Why?
|
Dehydration | 1 | 1986 | 216 | 0.000 |
Why?
|
Aspergillosis | 1 | 1986 | 242 | 0.000 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1985 | 176 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1979 | 13000 | 0.000 |
Why?
|
Vitamin B 12 | 1 | 1986 | 529 | 0.000 |
Why?
|
Substance-Related Disorders | 1 | 1980 | 4423 | 0.000 |
Why?
|
Membrane Potentials | 1 | 1986 | 1091 | 0.000 |
Why?
|
Time Factors | 1 | 2005 | 40214 | 0.000 |
Why?
|
Peroxidase | 1 | 1986 | 610 | 0.000 |
Why?
|
Education, Medical, Undergraduate | 1 | 1992 | 1085 | 0.000 |
Why?
|
Hydrogen Peroxide | 1 | 1986 | 740 | 0.000 |
Why?
|
Abscess | 1 | 1986 | 606 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 1980 | 5887 | 0.000 |
Why?
|
Dogs | 1 | 1986 | 3844 | 0.000 |
Why?
|
Cricetinae | 1 | 1985 | 2423 | 0.000 |
Why?
|
Hemoglobin C | 1 | 1980 | 21 | 0.000 |
Why?
|
Water | 1 | 1986 | 1421 | 0.000 |
Why?
|
Phosphorylation | 1 | 1991 | 8314 | 0.000 |
Why?
|
Oxygen Consumption | 1 | 1986 | 1880 | 0.000 |
Why?
|
Maximal Expiratory Flow Rate | 1 | 1979 | 42 | 0.000 |
Why?
|
Residual Volume | 1 | 1979 | 40 | 0.000 |
Why?
|
Functional Residual Capacity | 1 | 1979 | 70 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 1995 | 14718 | 0.000 |
Why?
|
Peak Expiratory Flow Rate | 1 | 1979 | 143 | 0.000 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 1979 | 93 | 0.000 |
Why?
|
Total Lung Capacity | 1 | 1979 | 148 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1991 | 3703 | 0.000 |
Why?
|
Pedigree | 1 | 1986 | 4539 | 0.000 |
Why?
|
Pediatrics | 1 | 1994 | 3629 | 0.000 |
Why?
|
Osmolar Concentration | 1 | 1978 | 657 | 0.000 |
Why?
|
Extracellular Matrix | 1 | 1985 | 1739 | 0.000 |
Why?
|
Vital Capacity | 1 | 1979 | 996 | 0.000 |
Why?
|
Anemia | 1 | 1985 | 1514 | 0.000 |
Why?
|
Forced Expiratory Volume | 1 | 1979 | 1831 | 0.000 |
Why?
|
Treatment Outcome | 1 | 1999 | 65364 | 0.000 |
Why?
|
Cell Line | 1 | 1985 | 15597 | 0.000 |
Why?
|
Cell Differentiation | 1 | 1985 | 11665 | 0.000 |
Why?
|